Today: 9 June 2026
Browse Category

LSE:SSE.L 17 January 2026 - 2 March 2026

SSE share price rises after £600m capital securities call — what investors watch next

SSE share price rises after £600m capital securities call — what investors watch next

SSE PLC shares rose 1.7% to 2,623.2 pence by 0938 GMT after the company announced plans to redeem £600 million of capital securities in full on April 14. The stock traded near a 52-week high, while other UK utilities also gained. SSE said the securities’ listing will be cancelled after settlement. The company expects lower adjusted earnings per share for the year ending March 2026.
24 February 2026
··
SSE stock steadies near highs after £950m Scottish subsea cable plan drops

SSE stock steadies near highs after £950m Scottish subsea cable plan drops

SSE shares rose 0.1% to 2,653 pence in early London trading after the company named five contractors for up to £950 million of subsea network upgrades in Scotland. The framework, set for five years with an option to extend, is expected to support over 450 jobs annually. Investors now await SSE’s May 28 results update for details on spending and project delivery.
18 February 2026
···
SSE share price ticks higher as UK jobs data revives March BoE cut bets — what to watch next

SSE share price ticks higher as UK jobs data revives March BoE cut bets — what to watch next

SSE shares rose 0.5% to 2,621 pence in early London trading Tuesday, rebounding after a 1.3% drop. UK unemployment climbed to 5.2% and wage growth slowed, firming bets on a Bank of England rate cut in March. Investors await UK inflation data Wednesday and Ofgem’s RIIO-3 licence decision this month. SSE’s annual results are due May 28.
17 February 2026
···
SSE share price near a fresh high — what investors are watching next

SSE share price near a fresh high — what investors are watching next

SSE shares rose 0.2% to 2,555 pence by 0847 GMT Wednesday, holding near record highs after hitting 2,578 pence earlier. The stock set a new 52-week high Tuesday, closing at 25.50 pounds on heavy volume. Recent filings showed small director share purchases under an incentive plan. SSE forecasts 2025/26 adjusted EPS of 144–152 pence and sharply higher network investment.
11 February 2026
·
SSE share price flat at 2,422p as a key trading update looms this week

SSE share price flat at 2,422p as a key trading update looms this week

SSE shares closed flat at 2,422 pence Friday after touching a 52-week high earlier in the session. The company paid an interim dividend of 21.4 pence per share, with directors reinvesting through share schemes. The FTSE 100 rose 0.5% for a seventh straight monthly gain, while sterling slipped 0.6% against the dollar. SSE will issue its third-quarter trading update on Feb. 4.
1 February 2026
·
SSE share price slips in London as UK wealth fund spotlights the power grid; Feb update looms

SSE share price slips in London as UK wealth fund spotlights the power grid; Feb update looms

SSE shares slipped 0.2% to 2,408 pence by 0924 GMT, trailing the FTSE 100’s 0.5% gain. The UK National Wealth Fund confirmed a financial guarantee for SSEN Transmission’s grid upgrades as part of a new five-year strategy. SSE will pay its interim dividend on Jan. 30 and report third-quarter results on Feb. 4. The stock remains near a 52-week high after gaining 52% in the past year.
29 January 2026
···
SSE stock price edges up in London as Europe doubles down on 100GW North Sea wind plan

SSE stock price edges up in London as Europe doubles down on 100GW North Sea wind plan

SSE shares rose 0.2% to 2,326 pence by 0902 GMT after securing a 20-year contract for 1.4 GW of offshore wind in the UK’s latest CfD auction. The company’s Berwick Bank project will receive £89.49 per megawatt hour, inflation-adjusted. SSE’s market cap stood near £27.9 billion. Britain and other European countries plan to sign a pact Monday for 100 GW of joint offshore wind projects.
26 January 2026
··

Stock Market Today

  • Nuvalent Shares Surge Near $124 Following GSK's $10.6 Billion Buyout Offer
    June 9, 2026, 10:35 AM EDT. Nuvalent's stock jumped 38.9% to $122.93 after GSK announced a $10.6 billion cash acquisition at $124 per share, reflecting a 40% premium to the last close. The deal highlights GSK's strategic move to expand its oncology portfolio beyond its current 6% share of sales, aiming to capitalize on Nuvalent's two lung cancer drugs pending FDA decisions this year. The tender offer needs the approval of at least half of Nuvalent's Class A shares and U.S. antitrust clearance. Early analyst reactions included target price adjustments but echoed caution over valuation. Nuvalent's pipeline products could face competition from existing ALK-targeted therapies by Pfizer and Roche.

Latest articles

Autozi Shares Jump 400%, Filing Flags Risks for AZI

Autozi Shares Jump 400%, Filing Flags Risks for AZI

9 June 2026
Autozi Internet Technology shares soared over 400% to $5.69 in early Nasdaq trading after a 10-for-1 share consolidation slashed its share count to about 4.49 million, but the surge contrasts with a 63.1% revenue drop, 82.5% plunge in gross profit, and widened net loss, with the company warning of “substantial doubt” about its ability to continue as a going concern.
Redwire Shares Slip After $500 Million Stock Offering Filed

Redwire Shares Slip After $500 Million Stock Offering Filed

9 June 2026
Redwire Corp shares plunged 6.5% to $17.37 after launching a $500 million at-the-market stock program, raising dilution risks for investors as the company seeks flexible funding despite recent record backlog and strong revenue growth; the drop contrasted with gains at other space stocks, highlighting investor concern over potential share issuance.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

9 June 2026
Nuvalent shares soared 38.9% to $122.93, just below GSK’s $124-a-share cash offer after the $10.6 billion buyout was announced, as investors bet on the deal closing with Nuvalent’s two lead lung-cancer drugs already under FDA review and a 40% premium to the last closing price driving the morning’s merger-arb trade.
Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
Go toTop